Profiles in Medicine
Casey McPherson Shares His Journey With Rare Drug Development and AlphaRose Therapeutics
Published: January 29th 2025 | Updated: January 29th 2025Casey McPherson, Founder and CEO of AlphaRose Therapeutics (formerly Chrysalis Genetics), talks about his daughter's rare genetic condition, and how it led him to antisense oligonucleotides (ASOs) and therapeutic development for rare diseases.
Biotech in the Empire State: Building a World-Class Bioscience Ecosystem in New York
January 3rd 2025Jennifer Hawks Bland, CEO of NewYorkBIO, shares her journey from litigation to biotech leadership, discusses fostering innovation in New York's thriving bioscience ecosystem, and outlines her vision for the state as a global biotech hub.
Industry Trends, Policy Challenges, and Educational Initiatives with Joseph Panetta
October 1st 2024Joseph Panetta, President and CEO of Biocom California, shares his insights on biotech industry trends, policy challenges, and educational initiatives, drawing from over 25 years of leadership in California’s thriving life sciences sector.
Max Colao Shares How OncoVerity is Pioneering Oncology Solutions
September 24th 2024Max Colao, CEO of OncoVerity, discusses his extensive experience in the biotech industry and shares how his company is harnessing computational biology and machine learning to develop personalized cancer treatments that aim to reshape the future of oncology care.
Elyse Blazevich on Driving Innovation in Colorado's Thriving Life Sciences Ecosystem
September 17th 2024Elyse Blazevich discusses the Colorado Bioscience Association’s efforts to support the state’s life sciences sector by fostering partnerships, advocating for industry growth, and building a diverse talent pipeline.
